S. Réjiba

K‐ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment

A. Hajri, S. Wack, M. Aprahamian, 2007, Cancer science.

Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.

Sophie J Deharvengt, A. Hajri, S. Wack, 2007, International journal of oncology.

Oncosuppressive Suicide Gene Virotherapy “PVH1-yCD/5-FC” for Pancreatic Peritoneal Carcinomatosis Treatment: NFκB and Akt/PI3K Involvement

A. Hajri, C. Parmentier, A. Masmoudi, 2013, PloS one.

Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer.

P. Couvreur, A. Hajri, L. H. Reddy, 2011, Nanomedicine : nanotechnology, biology, and medicine.

Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies.

A. Hajri, Céline Parmentier, C. Parmentier, 2009, Neoplasia.

Telomerase transcriptional targeting of inducible Bax/TRAIL gene therapy improves gemcitabine treatment of pancreatic cancer.

A. Hajri, S. Wack, M. Aprahamian, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.